Single center experience with subcutaneous ICD in combination with previously implanted endocardial or epicardial antibradycardia or cardiac resynchronization devices

FUNDING ACKNOWLEDGEMENTS: Type of funding sources: None. BACKGROUND: Subcutaneous ICD (S-ICD) is an established therapy for prevention of sudden cardiac death due to ventricular arrhythmias (VA). One major drawback of the S-ICD is the lack of antibradycardia pacing. Theroretically the S-ICD can be u...

Descripción completa

Detalles Bibliográficos
Autores principales: Som, Z, Nagy, Z, Kassa, K I, Mladoniczky, S, Kardos, A, Foldesi, C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
14.2 - Implantable Cardioverter-Defibrillator (ICD)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207488/
http://dx.doi.org/10.1093/europace/euad122.432

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207488/
http://dx.doi.org/10.1093/europace/euad122.432

Ejemplares similares